Samuel D. Isaly, 10% Owner at Audentes Therapeutics, Inc. (BOLD), sold 672,000 shares at $28.25 ($19.0M) on 2017-09-29, disclosed to the SEC on 2017-09-29.
Open-market sale of $19.0M BOLD by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RYTM | BUY | 2017-10-10 | $6.0M | — | Filing → |
| ROKA | SELL | 2017-09-28 | $202K | — | Filing → |
| GKOS | SELL | 2017-09-05 | $22.5M | — | Filing → |